Production of uniform

Assay and Drug Development Technologies

Volumn 13, Issue 9, 2015, Pages 570-583

  Singh, Manjulata ^a   Close, David A ^a   Mukundan, Shilpaa ^a   Johnston, Paul A ^a,b   Sant, Shilpa ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c University of Pittsburgh   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; DIMETICONE; EPIDERMAL GROWTH FACTOR RECEPTOR; ANTINEOPLASTIC AGENT; HYDROGEL;

ARTICLE; BREAST CANCER; CANCER CELL LINE; DRUG SCREENING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH THROUGHPUT SCREENING; HYDROGEL; IN VITRO STUDY; MICROARRAY KIT; MICROWELL PLATE; MORPHOLOGY; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR MODEL; TUMOR SPHEROID; TUMOR VOLUME; UTERINE CERVIX CANCER; CELL CULTURE TECHNIQUE; CELL SURVIVAL; DRUG EFFECTS; HEAD AND NECK TUMOR; HUMAN; MCF-7 CELL LINE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TISSUE MICROARRAY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; HEAD AND NECK NEOPLASMS; HUMANS; HYDROGEL; MCF-7 CELLS; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TUMOR MICROENVIRONMENT;

EID: 84948420765     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2015.662     Document Type: Article

References (43)

1. Zumsteg A, Christofori G: Corrupt policemen: inflammatory cells promote tumor angiogenesis. Curr Opin Oncol 2009;21:60-70.
2. Weigelt B, Bissell MJ: Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 2008;18:311-321.
3. Pietras K, Ostman A: Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 2010;316:1324-1331.
4. Finger EC, Giaccia AJ: Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 2010;29:285-293.
5. Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW: The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 2002;70:537-546.
6. Bin Kim J, Stein R, OHare MJ: Three-dimensional in vitro tissue culture models of breast cancer-a review. Breast Cancer Res Treatment 2004;85: 281-291.
7. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA: Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 2010;148:3-15.
8. Mueller-Klieser W: Tumor biology and experimental therapeutics. Crit Rev Oncol Hematol. Nov-Dec 2000;36:123-139.
9. Ehsan SM, Welch-Reardon KM, Waterman ML, Hughes CCW, George SC: A threedimensional in vitro model of tumor cell intravasation. Integr Biol 2014;6:603-610.
10. Szot CS, Buchanan CF, Freeman JW, Rylander MN: In vitro angiogenesis induced by tumor-endothelial cell co-culture in bilayered, collagen I hydrogel bioengineered tumors. Tissue Eng Part C Methods 2013;19:864-874.
11. Lu P, Weaver VM, Werb Z: The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012;196:395-406.
12. Hielscher AC, Gerecht S: Engineering approaches for investigating tumor angiogenesis: exploiting the role of the extracellular matrix. Cancer Res 2012; 72:6089-6096.
13. Infanger D, Pathi S, Fischbach C: Microenvironmental regulation of tumor angiogenesis: biological and engineering considerations. In: Biophysical Regulation of Vascular Differentiation and Assembly. Gerecht S (ed.), pp. 167-202. Springer, New York, 2011.
14. Stroock AD, Fischbach C: Microfluidic culture models of tumor angiogenesis. Tissue Eng Part A 2010;16:2143-2146.
15. Weigelt B, Lo A, Park C, Gray J, Bissell M: HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res Treatment 2010;122:35-43.
16. Ong SM, Zhao ZQ, Arooz T, et al.: Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. Biomaterials 2010;31:1180-1190.
17. Lin R-Z, Chang H-Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 2008;3:1172-1184.
18. West CML, Moore JV: Mechanisms behind the resistance of spheroids to photodynamic treatment: a flow cytometry study. Photochem Photobiol 1992; 55:425-430.
19. Bae H, Chu H, Edalat F, et al.: Development of functional biomaterials with micro- and nanoscale technologies for tissue engineering and drug delivery applications. J Tissue Eng Regen Med 2014;8:1-14.
20. Fukuda J, Khademhosseini A, Yeh J, et al.: Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components. Biomaterials 2006;27:1479-1486.
21. Karp JM, Yeh J, Eng G, et al.: Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip 2007;7:786-794.
22. Kwon CH, Wheeldon I, Kachouie NN, et al.: Drug-eluting microarrays for cellbased screening of chemical-induced apoptosis. Anal Chem 2011;83:4118-4125.
23. Khademhosseini A, Yeh J, Jon S, et al.: Molded polyethylene glycol microstructures for capturing cells within microfluidic channels. Lab Chip 2004;4:425-430.
24. Victor VM, Nunez C, DOcon P, Taylor CT, Esplugues JV, Moncada S: Regulation of oxygen distribution in tissues by endothelial nitric oxide. Circ Res 2009; 104:1178-1183.
25. Revzin A, Russell RJ, Yadavalli VK, et al.: Fabrication of poly(ethylene glycol) hydrogel microstructures using photolithography. Langmuir 2001;17:5440-5447.
26. Kenny PA, Lee GY, Myers CA, et al.: The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007;1:84-96.
27. Hwang YS, Chung BG, Ortmann D, Hattori N, Moeller HC, Khademhosseini A: Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A 2009;106:16978-16983.
28. Zhang C, Cao S, Toole BP, Xu Y: Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: a model for solid-cancer initiation and early development. Int J Cancer 2015;136:2001-2011.
29. Liao D, Johnson R: Hypoxia: A key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007;26:281-290.
30. Yu H, Mouw JK, Weaver VM: Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol 2011;21:47-56.
31. Tse JM, Cheng G, Tyrrell JA, et al.: Mechanical compression drives cancer cells toward invasive phenotype. Proc Natl Acad Sci U S A 2012;109:911-916.
32. Vorsmann H, Groeber F, Walles H, et al.: Development of a human threedimensional organotypic skin-melanoma spheroid model for in vitro drug testing. Cell Death Dis 2013;4:e719.
33. Chen LF, Cohen EE, Grandis JR: New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors. Clin Cancer Res 2010;16:2489-2495.
34. Egloff AM, Grandis JR: Improving response rates to EGFR-targeted therapies for head and neck squamous cell carcinoma: candidate predictive biomarkers and combination treatment with Src inhibitors. J Oncol 2009;2009:896407.
35. Leeman RJ, Lui VW, Grandis JR: STAT3 as a therapeutic target in head and neck cancer. Expert Opin Biol Ther 2006;6:231-241.
36. Quesnelle KM, Boehm AL, Grandis JR: STAT-mediated EGFR signaling in cancer. J Cell Biochem 2007;102:311-319.
37. Brockstein B: Management of recurrent head and neck cancer: recent progress and future directions. Drugs 2011;71:1551-1559.
38. Goerner M, Seiwert TY, Sudhoff H: Molecular targeted therapies in head and neck cancer-an update of recent developments. Head Neck Oncol 2010;2: 8-12.
39. Stransky N, Egloff, AM, Tward, AD, et al.: The mutational landscape of head and neck squamous cell carcinoma. Science 2012;333:1157-1160.
40. Ramqvist T, Dalianis T: Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 2010;16:1671-1677.
41. Denaro N, Russi EG, Adamo V, Colantonio I, Merlano MC: Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions. Oncology 2011;81:21-29.
42. Li H, Wawrose, JS, Gooding WE, et al.: Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection. Mol Cancer Res 2014;12:571-582.
43. Perez-Ordonez B, Beauchemin M, Jordan RCK: Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006;59:445-453.